DoW Alzheimer’s Transforming Diagnosis Award

The FY26 Alzheimer’s Research Program Transforming Diagnosis Award funds non-incremental research aimed at overcoming barriers to diagnosis, disease monitoring, and prognosis for Alzheimer’s disease and related dementias. Eligible applicants include U.S. Department of War organizations and foreign or domestic, for-profit or nonprofit, public or private organizations; awards go to organizations, not individuals. The program expects to fund about two awards with roughly $3.2 million total, with a cap of $1.5 million in total costs for a single-PI application or $1.7 million combined for the career initiation or transition partnership option. The project period is up to 4 years, cost sharing is not required, and clinical trials and animal research are not allowed. Community collaboration is required for studies that prospectively enroll human subjects, and there is no requirement for a specific population such as Service Members or Veterans.

✳ AI-generated summary — verify against the announcement

• Science and Technology and other Research and Development
• Research & Discovery
• Patients & People with Health Conditions
• Researchers & Scholars
• Aging, Dementia & Caregiving
• Biomedical & Disease Research

• ✓ Unrestricted